Americana Partners LLC Buys New Position in UnitedHealth Group Incorporated $UNH

Americana Partners LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 30,938 shares of the healthcare conglomerate’s stock, valued at approximately $11,357,000.

Other institutional investors have also made changes to their positions in the company. Left Brain Wealth Management LLC increased its holdings in UnitedHealth Group by 480.4% in the 3rd quarter. Left Brain Wealth Management LLC now owns 5,816 shares of the healthcare conglomerate’s stock valued at $2,135,000 after buying an additional 4,814 shares during the period. Modera Wealth Management LLC boosted its position in shares of UnitedHealth Group by 1.9% during the 3rd quarter. Modera Wealth Management LLC now owns 9,884 shares of the healthcare conglomerate’s stock worth $3,628,000 after acquiring an additional 185 shares in the last quarter. State of Wyoming increased its stake in UnitedHealth Group by 279.3% in the third quarter. State of Wyoming now owns 5,742 shares of the healthcare conglomerate’s stock valued at $2,108,000 after acquiring an additional 4,228 shares during the last quarter. CFC Planning Co LLC raised its position in UnitedHealth Group by 9.0% during the third quarter. CFC Planning Co LLC now owns 17,787 shares of the healthcare conglomerate’s stock valued at $6,530,000 after purchasing an additional 1,471 shares in the last quarter. Finally, Petros Family Wealth LLC raised its position in UnitedHealth Group by 4.4% during the third quarter. Petros Family Wealth LLC now owns 9,323 shares of the healthcare conglomerate’s stock valued at $3,422,000 after purchasing an additional 392 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Improving margins and higher price target: Morgan Stanley said UnitedHealth’s margins are recovering, with Medicare operations returning to a more normal range, and raised its price target. However, commercial insurance, Medicaid and increased AI-related spending remain important execution tests. UnitedHealth is bouncing back, but a major risk remains
• Positive Sentiment: Recent earnings beat and raised guidance: UnitedHealth’s latest quarterly results exceeded expectations for both earnings and revenue, and the company raised its outlook. The earnings recovery supports the case that operating performance is stabilizing after earlier pressure. Why Did UnitedHealth Raise Guidance After Its Quarterly Beat?
• Positive Sentiment: Dividend appeal: UnitedHealth is highlighted as a major healthcare dividend payer, potentially supporting demand from income-focused investors. The article also cautions that dividend safety should be assessed alongside payout sustainability and business risks. $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
• Neutral Sentiment: Analyst estimates are mixed: Zacks Research maintained a “Hold” rating and projects roughly $20.54 in FY2026 EPS, close to the broader consensus near $20.62. It raised several longer-term quarterly estimates but lowered others, including Q1 2027, Q1 2028 and Q2 2028.
• Negative Sentiment: Near-term earnings pressure: Zacks Research issued a negative estimate for fourth-quarter earnings, adding to concerns that high medical utilization and costs could limit profitability despite the Medicare recovery. Zacks Research Has Negative Estimate for UNH Q4 Earnings

UnitedHealth Group Trading Down 1.0%

NYSE UNH opened at $406.67 on Friday. The company has a market cap of $365.02 billion, a price-to-earnings ratio of 23.23, a price-to-earnings-growth ratio of 1.49 and a beta of 0.60. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The business’s fifty day moving average is $390.20 and its 200 day moving average is $362.40.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same period last year, the company earned $2.59 earnings per share. The business’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Sanford C. Bernstein reduced their target price on UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a report on Wednesday, October 14th. TD Cowen reissued a “hold” rating and set a $402.00 price target on shares of UnitedHealth Group in a report on Thursday, October 15th. Evercore raised their price objective on UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a research note on Tuesday, July 7th. Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Finally, JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a research note on Friday, October 16th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $463.93.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.19% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.